180 related articles for article (PubMed ID: 37168981)
1. Development of a reference and proficiency chemical list for human steatosis endpoints
Kubickova B; Jacobs MN
Front Endocrinol (Lausanne); 2023; 14():1126880. PubMed ID: 37168981
[TBL] [Abstract][Full Text] [Related]
2. Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for
Jacobs MN; Kubickova B; Boshoff E
Front Toxicol; 2022; 4():880818. PubMed ID: 35795225
[TBL] [Abstract][Full Text] [Related]
3. Regarding the references for reference chemicals of alternative methods.
Kolle SN; Hill E; Raabe H; Landsiedel R; Curren R
Toxicol In Vitro; 2019 Jun; 57():48-53. PubMed ID: 30738888
[TBL] [Abstract][Full Text] [Related]
4. Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents.
Al-Eryani L; Wahlang B; Falkner KC; Guardiola JJ; Clair HB; Prough RA; Cave M
Toxicol Pathol; 2015 Jun; 43(4):482-97. PubMed ID: 25326588
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.
Rodrigues RM; Branson S; De Boe V; Sachinidis A; Rogiers V; De Kock J; Vanhaecke T
Arch Toxicol; 2016 Mar; 90(3):677-89. PubMed ID: 25716160
[TBL] [Abstract][Full Text] [Related]
7. Development of a QSAR model to predict hepatic steatosis using freely available machine learning tools.
Cotterill J; Price N; Rorije E; Peijnenburg A
Food Chem Toxicol; 2020 Aug; 142():111494. PubMed ID: 32553933
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
9. Transcript and protein marker patterns for the identification of steatotic compounds in human HepaRG cells.
Lichtenstein D; Mentz A; Schmidt FF; Luckert C; Buhrke T; Marx-Stoelting P; Kalinowski J; Albaum SP; Joos TO; Poetz O; Braeuning A
Food Chem Toxicol; 2020 Nov; 145():111690. PubMed ID: 32810590
[TBL] [Abstract][Full Text] [Related]
10. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
11. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.
Willebrords J; Pereira IV; Maes M; Crespo Yanguas S; Colle I; Van Den Bossche B; Da Silva TC; de Oliveira CP; Andraus W; Alves VA; Cogliati B; Vinken M
Prog Lipid Res; 2015 Jul; 59():106-25. PubMed ID: 26073454
[TBL] [Abstract][Full Text] [Related]
12. In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity.
Müller FA; Stamou M; Englert FH; Frenzel O; Diedrich S; Suter-Dick L; Wambaugh JF; Sturla SJ
Arch Toxicol; 2023 Jun; 97(6):1701-1721. PubMed ID: 37046073
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hepatic steatosis by dietary fatty acids.
Ferramosca A; Zara V
World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
[TBL] [Abstract][Full Text] [Related]
14. The OECD validation program of the H295R steroidogenesis assay: Phase 3. Final inter-laboratory validation study.
Hecker M; Hollert H; Cooper R; Vinggaard AM; Akahori Y; Murphy M; Nellemann C; Higley E; Newsted J; Laskey J; Buckalew A; Grund S; Maletz S; Giesy J; Timm G
Environ Sci Pollut Res Int; 2011 Mar; 18(3):503-15. PubMed ID: 20890769
[TBL] [Abstract][Full Text] [Related]
15. Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells.
Di Cocco S; Belloni L; Nunn ADG; Salerno D; Piconese S; Levrero M; Pediconi N
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31380833
[TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
17. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.
Derdak Z; Villegas KA; Harb R; Wu AM; Sousa A; Wands JR
J Hepatol; 2013 Apr; 58(4):785-91. PubMed ID: 23211317
[TBL] [Abstract][Full Text] [Related]
19. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models.
Kim DY; Chung KS; Park JY; Gee HY
Biomed Pharmacother; 2023 May; 161():114445. PubMed ID: 36842353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
